San Diego-based medical device maker Aethlon Medical Inc. has received a $22.8 million government subcontract to collaborate with the Columbus, Ohio-based nonprofit research and development organization Battelle Memorial Institute.
The contract was awarded by the Defense Advanced Research Projects Agency to develop a sepsis treatment. Sepsis, commonly known as blood poisoning, is a severe and often fatal infection of the blood that is a common result of wartime injury.
Aethlon is a publicly traded company that has a market capitalization of $18.5 million.
— SDBJ Staff Report